BREAKING NEWS: FDA Recommends New COVID-19 shots to Target Omicron with Jabs expected to Roll Out in October
A panel of independent advisors has recommended new formulations for the
COVID-19 vaccines to specifically target the
Omicron variant.
By a 19-2 vote, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) approved plans to rollout newly formulated vaccines this fall - citing the vaccine resistant traits of the Omicron variant.
Dr Peter Marks, director of the Center for Biologics Evaluation and Research, the Food and Drug Administration's (
FDA) top regulatory body for vaccines, said Tuesday morning he hoped to make the new shots available as early as this October.
The move opens the door for fourth vaccine shots for the general American population and fifth shots for the immunocompromised and for people over 50.
FDA panel recommends new COVID-19 shots to target the Omicron variant | Daily Mail Online